Picture of IDEXX Laboratories logo

IDXX — IDEXX Laboratories News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

IDEXX rises after beating quarterly revenue estimates

** Shares of animal diagnostics maker IDEXX Laboratories IDXX.O rise 1.13% to $678.02 premarket

** Co reports Q4 adj. profit of $3.08/shr vs analysts' average estimate of $2.93/shr - LSEG data

** Brokerage Leerink Partners said non‑wellness vet visits, which drive most recurring diagnostics revenue, held up better than overall visit volumes in Q4

** Co's quarterly revenue of $1.091 billion beats analysts' average expectation of $1.073 billion

** Shares were up ~64% in 2025

 (Reporting by Sahil Pandey in Bengaluru)

 ((Sahil.Pandey@thomsonreuters.com))

Recent news on IDEXX Laboratories

See all news